What to make of the AstraZeneca vaccine data — and the surrounding controversy
(By Adam Feurerstein, Damian Garde, and Meg Tirrell for STAT) AstraZeneca’s up-and-down quest to develop a vaccine for Covid-19 stands
Read More(By Adam Feurerstein, Damian Garde, and Meg Tirrell for STAT) AstraZeneca’s up-and-down quest to develop a vaccine for Covid-19 stands
Read More(By Andrew Joseph for STAT) U.S. health officials raised concerns early Tuesday that positive results that AstraZeneca announced Monday for
Read More(By Bernard J. Wolfson for Kaiser Health News) As you surely know, this country’s covid vaccination effort has been plagued
Read More(By Maia Anderson for Becker’s Hospital Review) The FDA has fully approved the first COVID-19 test, the agency said March 17.
Read More(By Carmen Heredia Rodriguez for Kaiser Health News) It’s been a long, dark winter of covid concerns, stoked by high
Read MoreOfficials are warning the senior community to stop posting your COVID-19 vaccine card or Medicare ID card on social media.
Read More(By Juana Summers for NPR) There is little difference in reluctance to take the coronavirus vaccine among Black and white
Read More(By Mackenzie Bean for Becker’s Hospital Review) People who have more than five symptoms of COVID-19 during the first week of
Read More(By Scott Neuman for NPR) Health officials have relaxed federal COVID-19 guidance for nursing homes for the first time since
Read More(By Erica Carbajal for Becker’s Hospital Review) About 32 percent of people reported lingering symptoms at least 61 days after
Read More